KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Minority Interest (2016)

CRISPR Therapeutics AG's Minority Interest history spans 2 years, with the latest figure at -$51000.0 for Q3 2016.

  • For Q3 2016, Minority Interest changed N/A year-over-year to -$51000.0; the TTM value through Sep 2016 reached -$51000.0, changed N/A, while the annual FY2015 figure was -$27000.0, N/A changed from the prior year.
  • Minority Interest for Q3 2016 was -$51000.0 at CRISPR Therapeutics AG, down from -$27000.0 in the prior quarter.
  • Across five years, Minority Interest topped out at -$27000.0 in Q4 2015 and bottomed at -$51000.0 in Q3 2016.